Notes on Blarcamesine and APOE4 and EMA impact

Blarcamesine vs Donepezil -- long term comparison

Aducanumab, Blarcamesine, Donanemab and Lecanemab Compared!

Annovis and Anavex A2-73 Parkinson Data Comparison

Screening / Diagnostic Testing and the Receiver Operating Characteristics (ROC) Curve

Free Simple Normal Distribution Plotter

Tomato Data

Sullivan Cave Sump Trip 1985

Sullivan Cave Trip 1985-1

Sullivan Cave Trip 1986-1

Sullivan Cave Trip 1986-2

Sullivan Cave Trip July1986

Salamander Cave Circa 1985

U.S. Naval Training Station, Great Lakes, Illinois - 1943

Fort Gordon Basic Training 1962-1963

Mao A-Min Song Translations

Welcome!

This site serves to publish MAXimum HIGH TECH information, historical information, and information that is, for the most part, not available at any other website.

***LATEST ARTICLE***
Notes On APOE4 and Potential EMA Blarcamesine Approval
Some comments regarding patient APOE4 status and recent Anavex pre-publications, and their possible affect on EMA resubmission. ---Max


Be sure to check out similar articles by Piotr Pietrzkiewicz at his Bio_oko patreon blog. ---Max


Other Articles

Additionally, we have an article comparing the ADAS-Cog results of the four Alzheimer's drugs - Aducanumab, Blarcamesine, Donanemab and Lecanemab!

For Parkinson's Disease, an efficacy comparison of Annovis's drug and the Anavex drug.